Showing results (431-440 of 452) with videos related to

Sort By:
Pageof 46
Nature Communications|August 21, 2025
Genome-wide in vivo CRISPR screens identify GATOR1 complex as a tumor suppressor in Myc-driven lymphomaMargaret A Potts, Shinsuke Mizutani, Yexuan Deng, et al.
Blood Advances|October 20, 2020
Clinical MDR1 inhibitors enhance Smac-mimetic bioavailability to kill murine LSCs and improve survival in AML modelsEmma Morrish, Anthony Copeland, Donia M Moujalled, et al.
Nature Communications|September 11, 2020
MCL-1 gains occur with high frequency in lung adenocarcinoma and can be targeted therapeuticallyEnkhtsetseg Munkhbaatar, Michelle Dietzen, Deepti Agrawal, et al.
Nature Communications|June 21, 2020
MLKL trafficking and accumulation at the plasma membrane control the kinetics and threshold for necroptosisAndre L Samson, Ying Zhang, Niall D Geoghegan, et al.
Cell|September 12, 2015
Targeting of Fn14 Prevents Cancer-Induced Cachexia and Prolongs SurvivalAmelia J Johnston, Kate T Murphy, Laura Jenkinson, et al.
Blood|April 7, 2021
Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemiasRachel Thijssen, Sarah T Diepstraten, Donia Moujalled, et al.
Nature Communications|November 13, 2025
Non-apoptotic caspase-8 is critical for orchestrating exaggerated inflammation during severe SARS-CoV-2 infectionStefanie M Bader, Lena Scherer, Reet Bhandari, et al.
Nature Communications|March 18, 2015
A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine productionUeli Nachbur, Che A Stafford, Aleksandra Bankovacki, et al.
Journal of Medicinal Chemistry|April 2, 2014
Birinapant, a smac-mimetic with improved tolerability for the treatment of solid tumors and hematological malignanciesStephen M Condon, Yasuhiro Mitsuuchi, Yijun Deng, et al.
Pageof 46